![]() |
|
|
Vol. 293, Issue 2, 522-529, May 2000
Research Laboratories, Nippon Shinyaku Co., Ltd., Nishiohji Hachijo Minami-ku, Kyoto, Japan
| |
Abstract |
|---|
|
|
|---|
The hypoxic injury was induced in rat cerebrocortical slices by the
exposure to hypoxia for 45 min in the absence or presence of 3 mM
glucose, followed by reoxygenation for 5 h. The injury was more
pronounced in the absence of glucose (severe hypoxic injury) than in
the presence of glucose (mild hypoxic injury). A novel
Na+/Ca2+ channel blocker, NS-7
[4-(4-fluorophenyl)-2-methyl-6-(5-piperidinopentyloxy) pyrimidine
hydrochloride], at 3 to 30 µM inhibited preferentially the severe
hypoxic injury, whereas MK-801,
-conotoxin GVIA (
-CTX), and
NG-nitro-L-arginine methylester
suppressed preferentially the mild hypoxic injury. The extracellular
cyclic GMP formation, a marker of nitric oxide synthesis, was enhanced
during hypoxia, although the extent was greater in the
absence of glucose. As observed in the hypoxic injury, NS-7
preferentially inhibited the cyclic GMP formation induced by severe
hypoxic insults, whereas MK-801 or
-CTX reduced it under mild
hypoxic condition. When 30 to 50 mM KCl was applied to normoxic slices,
a concentration-dependent increase in the extracellular cyclic GMP
formation was observed. NS-7 blocked the cyclic GMP formation induced
by 50 mM KCl but not by 30 to 40 mM KCl, whereas
-CTX suppressed
only the 30 mM KCl-evoked response. In primary neuronal culture, NS-7
reversed KCl-induced increase in intracellular Ca2+ in
which the inhibition was marked when the KCl concentration was
increased. These findings suggest that NS-7, unlike other neuroprotective compounds used in this study, is more effective in
severe hypoxic injury. The highly voltage-dependent Ca2+
channel blockade may contribute to the mode of neuroprotective action
of NS-7.
| |
Introduction |
|---|
|
|
|---|
Although
the cellular mechanisms underlying neuronal death caused by cerebral
ischemia are not fully understood, perturbation of intracellular
Ca2+ homeostasis and subsequent activation of a
variety of Ca2+-related enzymes, including
nitric-oxide synthase (NOS), phospholipases, and proteases, may
participate in the pathogenesis of ischemic brain damage (Orrenius et
al., 1989
; Choi, 1990
, 1992
; Kristián and Siesjö, 1998
).
Several lines of evidence have demonstrated that the elevation of
intracellular free Ca2+ concentrations
([Ca2+]i) under ischemic
or hypoxic conditions is attributable to the activation of
voltage-gated Na+ and Ca2+
channels (Buchan et al., 1994
; Lysko et al., 1994
; Lynch et al., 1995
;
Taylor and Meldrum, 1995
). A variety of Na+
channel blockers, such as tetrodotoxin (Lysko et al., 1994
) and phenytoin (Ratand et al., 1994
);
Ca2+ channel blockers, particularly an N-type
Ca2+ channel blocker, SNX-111, a synthetic
peptide derived from
-conotoxin MVIIA (Buchan et al., 1994
); and a
P/Q-type Ca2+ channel blocker,
-agatoxin IVA
(
-Aga) (Asakura et al., 1997
), have been demonstrated to protect
neurons against focal as well as global cerebral ischemia in rats. We
have reported previously that the hypoxic injury induced in rat
cerebrocortical slices by a transient exposure to hypoxia/glucose
deprivation, followed by reoxygenation, is abolished by the removal of
extracellular Ca2+ or an intracellular
Ca2+ chelator,
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid/acetoxymethyl ester (BAPTA/AM) (Tatsumi et al., 1998b
).
Moreover, the hypoxic injury in rat cerebrocortical slices is
suppressed by a variety of Na+ channel blockers
and Ca2+ channel blockers, including an N-type
blocker,
-conotoxin GVIA (
-CTX), and
-Aga (Tatsumi et al.,
1998b
).
NS-7 [4-(4-fluorophenyl)-2-methyl-6-(5-piperidinopentyloxy)
pyrimidine hydrochloride] is a novel
Na+/Ca2+ channel blocker
developed in our laboratories. It shows an almost equipotent blocking
action on tetrodotoxin-sensitive Na+ current as
well as L-type and N-type Ca2+ currents with
IC50 values of 4.5 to 7.8 µM in patch-clamp
configuration using NG 108-15 cells (Suma et al., 1997
), displaces
[3H]batrachotoxin binding with
Ki of 1 µM in rat brain membrane (Shimidzu et al., 1997
), and inhibits the KCl-evoked nitric oxide (NO)
synthesis mediated through L-type and P/Q-type
Ca2+ channels with IC50
values of 2.5 and 3.1 µM, respectively, in primary neuronal culture
(Oka et al., 1999
). This compound has been shown to reduce the size of
cerebral infarction as well as activation of calpain, a
Ca2+-activated protease, caused by permanent
middle cerebral artery occlusion in rats (Takagaki et al., 1997
) and to
inhibit the hypoxic injury in rat cerebrocortical slices (Tatsumi et
al., 1998b
). We have found recently in primary neuronal culture that
NS-7 inhibits the NO synthesis induced by high concentrations (1-10
µM) of Bay K 8644, a Ca2+ channel agonist,
without affecting the responses of low concentrations (0.01-0.1 µM)
of Bay K 8644 (Oka et al., 1999
). Moreover, NS-7, unlike other
Na+ and Ca2+ channel
blockers, reduces the KCl (80 mM)-evoked or veratridine-stimulated dopamine release from rat striatum, measured by an intracerebral microdialysis, without changing spontaneous or evoked release induced
by 25 to 50 mM KCl (Itoh et al., 1998
). Taken together, it is suggested
that the blockade of Na+ and
Ca2+ channels by NS-7 is dependent on the
activity of these ion channels in which the compound blocks
preferentially the activated Na+ and
Ca2+ channels.
During cerebral ischemia, depletion of ATP causes a dysfunction of
Na+/K+-ATPase and leads to
the elevation of intracellular Na+ concentration,
which in turn depolarizes neuronal membranes and subsequent activation
of voltage-gated Na+ and
Ca2+ channels. Membrane depolarization occurring
after exposure to hypoxia or hypoxia/glucose deprivation, which is
known as an anoxic depolarization, has been considered to be closely
related to the neuronal injury (Boening et al., 1989
). Fowler and Li
(1998)
have reported that in CA1 pyramidal neurons of rat hippocampal
slices hypoxia/glucose deprivation for 10 min causes a marked decrease in tissue ATP content and anoxic depolarization. They also have shown
that tetrodotoxin (1 µM) inhibits the anoxic depolarization as well
as the loss of tissue ATP, indicating a close relationship between the
ATP depletion and anoxic depolarization. The extent of tissue ATP
depletion depends largely on the severity of hypoxic insults.
Therefore, it seems probable that NS-7 blocks Na+
and Ca2+ channels more effectively in brain
tissues exposed to severe hypoxic insults than in those under mild
hypoxic condition. To ascertain this idea, the severity of the hypoxic
injury was controlled by changing the glucose concentration, and the
effect of NS-7 on severe and mild hypoxic injury was subsequently
examined in slices of rat cerebral cortex. The effect of this compound
on the hypoxia-induced enhancement of NO synthesis in the absence or
presence of low concentration of glucose was examined in rat cerebrocortical slices in relation to the action on the depolarization (KCl)-evoked NO synthesis. In addition, the mode of inhibition by NS-7
of KCl-induced elevation of
[Ca2+]i was investigated
in primary neuronal culture of mouse cerebral cortex and compared with
that of nifedipine.
| |
Materials and Methods |
|---|
|
|
|---|
Chemicals.
NS-7 and nifedipine were synthesized in our
chemical laboratories. The following chemicals and drugs were obtained
from commercial sources:
NG-nitro-L-arginine
methylester (L-NAME; Nacalai Tesque, Kyoto, Japan), 3-isobutyl-1-methylxanthine (IBMX; Sigma Chemical Co., St.
Louis, MO),
-CTX (Peptide Institute, Osaka, Japan), (+)MK-801 (Funakoshi, Tokyo, Japan), and cyclic GMP enzyme immunoassay system (Amersham Co., Buckinghamshire, UK). Other chemicals were all of
guaranteed grade.
Animals. Male 10- to 14-week-old Sprague-Dawley rats (Japan SLC, Shizuoka, Japan) and pregnant ddY strain mice (Japan SLC) were used. Rats were housed in groups of five to six, and mice were individually bred in a plastic cage in a room controlled at 21-25°C, 45 to 65% humidity, and maintained in an alternating 12-h light/dark cycle (lights automatically on at 8:00 AM). Food and water were freely given. All experiments were carried out in accordance with the Guide for the Care and Use of Laboratory Animals written by the Japanese Pharmacological Society.
Hypoxia/Reoxygenation-Induced Tissue Injury in Slices of Rat
Cerebral Cortex.
After immersing the whole brain in ice-cold 5%
glucose solution for 10 min, the cerebral cortex was dissected on ice,
and serial coronal sections of 500-µm thickness were prepared using a
McIlwain tissue chopper (Mickle Laboratory Engineering Co., Gomshall,
UK). The chopped tissue then was transferred to a glass dish containing
ice-cold Krebs-Ringer-bicarbonate solution (KRB; 118 mM NaCl, 4.7 mM
KCl, 2.54 mM CaCl2, 1.2 mM
MgCl2, 1.2 mM
KH2PO4, 25 mM
NaHCO3, and 11.5 mM D-glucose, pH
7.4), and each slice was gently isolated with forceps. A piece of the
slice was transferred to a 12-well plastic dish containing 2 ml of KRB
and was preincubated at 37°C for 1 h under continuous bubbling
with a gas mixture of 95% O2 and 5%
CO2. After preincubation, the slice was incubated in glucose-deprived KRB (in case of severe injury) or 3 mM
glucose-containing medium (in case of mild injury) at 37°C for 45 min
under continuous bubbling with 95% N2 and 5%
CO2, followed by reoxygenation for 5 h in
normal KRB. Tissue damage was assessed by the leakage of lactate
dehydrogenase (LDH) into the incubation medium. A 50-µl portion of
the incubation medium was taken at 5 h after the reoxygenation, and LDH activity in the medium was determined by using an enzymatic assay kit (Wako Pure Chemical, Osaka, Japan). LDH leakage was expressed
as the percentage of that in the normoxic group in which slices were
incubated for 5 h and 45 min in KRB under continuous bubbling with
95% O2 and 5% CO2. At the
end of experiments, brain slices were dissolved in 1 ml of 1 N NaOH,
and protein content was determined by the method of Bradford (1976)
using BSA as the standard.
Measurement of Tissue ATP Content and Extracellular Glutamate
during Exposure of Brain Slices to Hypoxic Insults.
Brain slices
were preincubated at 37°C for 1 h in normal KRB solution under
continuous bubbling with 95% O2, 5%
CO2 and then exposed for 45 min to hypoxia in the
absence or presence of 3 mM glucose. In the normoxia group, after
1 h of preincubation, slices were incubated at 37°C for 45 min
in normal KRB solution under continuous bubbling with 95%
O2, 5% CO2. At the end of
the 45-min incubation under normoxic or hypoxic condition, slices were
transferred to plastic tubes containing 1 ml of 0.4 N perchloric acid
and homogenized, while the incubation medium was used for glutamate
assay. The brain homogenates were centrifuged at 10,000g for
30 min, and the resultant supernatant was neutralized to pH 6.0 with a
10% K2CO3 solution. The
ATP content was determined by HPLC with spectrophotometric detection as
described previously (Tatsumi et al., 1998b
). In brief, a portion of
the neutralized supernatant was injected directly onto an HPLC system
composed of a pump (LC-6A; Shimadzu, Kyoto, Japan), a reversed-phase
separation column (250 × 4.6 mm, Wakosil II 5C18 RS; Wako Pure
Chemical), a UV spectrophotomonitor (SPD-6A; Shimadzu), and a
chromatocorder (Chromatopac C-R4A; Shimadzu). The column temperature
was 35°C. The mobile phase was 0.2 M ammonium dihydrogen phosphate
(pH 4.1) containing tetrabutylammonium hydrogen sulfate (50 mg/l)
(Aldrich, Milwaukee, WI) and 1% acetonitrile. The flow rate was 0.8 ml/min. ATP was detected at A260.
Measurement of Nitric Oxide (NO) Formation in Extracellular
Fluids.
The NO formation was estimated from cyclic GMP
accumulation in the extracellular fluids after addition of GTP, IBMX,
and the soluble fraction of rat cerebellum containing guanylate cyclase as described previously (Oka et al., 2000
). Briefly, the cerebral cortex and cerebellum were dissected on ice, and serial coronal sections of the cerebral cortex were prepared as described above. The
cerebellum was homogenized with 10 volumes of ice-cold buffer A (50 mM
Tris-HCl containing 1 mM EDTA, 1 mM dithiothreitol, and 200 mM
phenylmethylsulfonyl fluoride) using a Polytron homogenizer (PT 3000;
Kinematica AG, Littau, Switzerland). After centrifugation at
30,000g for 30 min, the supernatant fraction was used for
the source of guanylate cyclase. A cerebrocortical slice was
transferred to a 24-well plastic plate in which 2 ml of KRB was
included and preincubated at 37°C for 1 h under continuous
bubbling with 95% O2, 5%
CO2. After preincubation, the incubation medium
was discarded, and the slice was further incubated in 2 ml of oxygen-
and glucose-deprived KRB (severe hypoxic insults) or oxygen-deprived
but 3 mM glucose-containing medium (mild hypoxic insults) for 45 min
under continuous bubbling with 95% N2, 5%
CO2. In a set of experiments, normoxic slices were exposed to 30 to 50 mM KCl for 45 min to examine the effects of
drugs on the depolarization (KCl)-induced NO synthesis. To measure the
extracellular cyclic GMP formation during hypoxia or KCl stimulation,
0.5 mM GTP, 1 mM IBMX, and a 20-µl aliquot of the supernatant
fraction of rat cerebellum (containing 50-80 µg of protein) were
added to the incubation medium immediately after the exposure to
hypoxia or KCl stimulation. The cyclic GMP produced in the incubation
medium was measured by using the Amersham cyclic GMP enzyme immunoassay kit.
Primary Neuronal Culture.
Primary neuronal culture was
prepared from the cerebral cortex of fetal mice as described previously
(Ma et al., 1991
; Tatsumi et al., 1998a
). Briefly, the cerebral cortex
was dissected from 15-day-old fetal mouse brain, and the meninges were
carefully removed in a Ca2+-free Puck's solution
(pH 7.4). Tissues were minced and washed with
Ca2+-free Puck's solution, followed by treatment
with 0.1% trypsin dissolved in Ca2+-free Puck's
solution at 37°C for 5 min under a stream of 95% O2, 5% CO2. The trypsin
digestion was terminated by the addition of ice-cold Dulbecco's
modified Eagle's minimum essential medium (DMEM) supplemented with 30 mM D-glucose, 10 mM
N-tris(hydroxymethyl) methyl-2-aminoethanesulfonic acid,
10 mM HEPES, carbenicillin (0.1 mg/ml), streptomycin (0.1 mg/ml), and
20% horse serum, and tissues were triturated with a Pasteur pipette.
The dispersed cells were collected after centrifugation at
900g at 4°C for 2 min. The resultant pellet was
resuspended in DMEM followed by trituration, and then the cell
suspension was passed through a nylon sieve (mesh size, 60 µm). A
portion (1.5 ml) of the cell suspension containing 1.45 × 106 cells/ml was inoculated on a 35-mm
glass-bottom dish (MatTek, Ashland, MA). The medium was replaced by
freshly prepared DMEM containing 15% fetal calf serum, and cells were
successively incubated for 2 days. On the third day, cells were exposed
to 20 mM cytosine-
-D-arabinofuranoside dissolved in DMEM containing 15% horse serum for 24 h to prevent the growth of non-neuronal cells; then the culture medium was replaced
by freshly prepared DMEM supplemented with 15% horse serum.
Measurement of [Ca2+]i in
Primary Neuronal Culture.
The
[Ca2+]i was determined as
described previously (Oka et al., 1999
). Briefly, on the fifth day of
in vitro culture, cells were preloaded with 10 µM
fura-2/acetoxymethyl ester (AM) in 10 mM HEPES-NaOH (pH 7.05) buffer
containing 5.4 mM KCl, 130 mM NaCl, 2.5 mM CaCl2,
and 5.5 mM D-glucose at 37°C for 30 min, followed by
further incubation for 30 min to hydrolyze acetoxymethyl ester. The
fura-2-loaded cells were imaged on an inverted microscope (IMT-2;
Olympus, Tokyo, Japan), using a 40×, 0.6 numerical aperture immersion
objective (Olympus) and a charge-coupled device camera (C-2400-08;
Hamamatsu Photonics, Shizuoka, Japan) fitted with 500 television
line. A 75-W xenon arc lamp was used to provide fluorescence
excitation. Ratio images were obtained by acquiring pairs of images at
alternate excitation wavelength (340/380 nm) and filtering the emission
at 510 nm (OSP-3; Olympus). Images were recorded every 5 s with a
video camera (Hamamtsu Photonics) equipped with an Argus-50/CA system
(Hamamtsu Photonics), which controlled the image acquisition and
display. The fluorescence images of fura-2-loaded neurons were
corrected by subtracting the background images measured in a field
lacking neuronal cells. The images at individual wavelengths were
averaged over 32 frames. Cells were depolarized consecutively with 30, 40, and 50 mM KCl for 15 s at 5-min intervals in the absence or
presence of test compounds.
[Ca2+]i was monitored in
32 to 51 neurons, the average was calculated in one experiment, and
data were obtained from three to four experiments.
Statistical Analysis.
Statistical analyses were all
performed by using SAS program (SAS/STAT, Version 6; SAS Institute
Inc., Cary, NC). Unless otherwise indicated, data (real values) were
analyzed for statistical significance by Dunnett's test for multiple
comparison. In the set of experiments where the effects of NS-7 and
-CTX on KCl-evoked cyclic GMP formation were studied, data were
analyzed first by two-way ANOVA followed by Student's t
test to compare the data between the control and drug-treated groups at
the respective KCl concentration.
| |
Results |
|---|
|
|
|---|
Effect of NS-7 on Severe and Mild Hypoxic Injury in Slices of Rat
Cerebral Cortex.
As shown in Fig. 1,
when the rat cerebrocortical slices were exposed to oxygen- and
glucose-deprived medium for 45 min, followed by reoxygenation for
5 h, a marked LDH leakage was observed (severe hypoxic injury:
574.6 ± 50.4% of that in normoxic slices, mean ± S.E.,
n = 5). In the case of exposure to the medium devoid of oxygen but containing 3 mM glucose, the LDH leakage was less marked (mild hypoxic injury: 214.5 ± 16.4% of that in normoxic slices, n = 5). NS-7 (3-30 µM) produced a marked and
concentration-dependent reduction of LDH leakage caused by severe
hypoxic insult. The significant effect was observed at 3 µM and
greater (the values were 415.2 ± 48.0% at 3 µM,
n = 5, P < .05; 283.3 ± 23.4%
at 10 µM, n = 5, P < .01; and
245.8 ± 43.8% at 30 µM, n = 5, P < .01 by Dunnett's test). However, NS-7, even
at 30 µM, did not significantly inhibit the mild hypoxic injury.
|
Effects of MK-801,
-CTX, and L-NAME on Severe and
Mild Hypoxic Injury in Slices of Rat Cerebral Cortex.
In contrast
to the action of NS-7, MK-801 (1-3 µM) and
-CTX (5 µM)
significantly inhibited the mild hypoxic injury (Fig. 2B). The values in MK-801 (1 µM)-,
MK-801 (3 µM)-, and
-CTX-treated groups exposed to mild hypoxic
insults were 167.1 ± 7.8% (n = 5, P < .05), 149.8 ± 6.3% (n = 5, P < .01), and 96.0 ± 19.7% (n = 5, P < .01) of that in normoxic slices, respectively,
as compared with the control value (245.6 ± 20.1%,
n = 5). Both compounds, however, did not significantly
affect the LDH leakage caused by severe hypoxic insult (Fig. 2A). The
mild and severe hypoxic injury in rat cerebrocortical slices was
attenuated by L-NAME in a concentration-dependent manner, although higher concentrations of L-NAME
were needed to inhibit the severe injury than those for suppressing the
mild hypoxic injury (Fig. 3).
|
|
Enhancement of Extracellular Cyclic GMP Formation during Exposure
of Rat Cerebrocortical Slices to Severe and Mild Hypoxic Insults:
Effects of NS-7, MK-801, and
-CTX.
The formation of cyclic GMP
in the incubation medium containing the soluble fraction of rat
cerebellum, 0.5 mM GTP, and 1 mM IBMX was measured as an index of NO
synthesis. As shown in Fig. 4, the
extracellular cyclic GMP formation was enhanced during hypoxia,
although the enhancement was more marked in the absence of glucose
(15.9 ± 2.5 pmol/mg protein/45 min, n = 8, in
hypoxic slices; and 3.0 ± 0.4 pmol/mg protein/45 min,
n = 10, in normoxic slices) than in the presence of 3 mM glucose (Fig. 4B) (5.7 ± 0.4 pmol/mg protein/45 min,
n = 7). NS-7 (10 µM) strongly reversed the
augmentation of the cyclic GMP formation induced by severe hypoxic
insult (Fig. 4A, Experiment I: 534.9 ± 83.2% of normoxic slices,
n = 8, in control group and 246.5 ± 48.0%,
n = 10, in NS-7-treated group; P < .01) without significant inhibition of that caused by mild hypoxic
insult (Fig. 4B, Experiment I: 190.1 ± 14.9%, n = 7, in control group; and 149.2 ± 27.9%, n = 7, in NS-7-treated group). Conversely, both MK-801 (3 µM) and
-CTX (5 µM) showed preferential reduction of the cyclic GMP formation caused
by mild hypoxic insult (Fig. 4B, Experiment II). The values in control,
MK-801 (3 µM)-, and
-CTX-treated groups were 190.7 ± 23.0%
(n = 5), 96.9 ± 20.7% (n = 5),
and 93.4 ± 13.6% (n = 5), respectively.
Significant inhibition was observed in the MK-801 (3 µM)-treated
group (P < .01) and
-CTX-treated groups
(P < .01). However, neither MK-801 nor
-CTX
produced any significant inhibition on the cyclic GMP formation induced
by severe hypoxic insult (Fig. 4A, Experiment II).
|
Depletion of Tissue ATP Content and Increase in Extracellular
Glutamate Concentration during Exposure of Rat Cerebrocortical Slices
to Hypoxia in the Absence or Presence of 3 mM Glucose.
As shown in
Fig. 5, the tissue ATP content in slices
exposed to hypoxia/glucose deprivation for 45 min was reduced to 5.4% of that in normoxic slices (0.27 ± 0.01 nmol/mg protein,
n = 6, in hypoxic slices; and 5.09 ± 0.35 nmol/mg
protein, n = 6, in normoxic slices), whereas the value
was 14.1% in slices exposed for 45 min to hypoxia with 3 mM glucose
(0.72 ± 0.02 nmol/mg protein, n = 6). Significant
differences were observed in both mild (P < .01 by
Dunnett's test) and severe hypoxic group (P < .01 by Dunnett's test). Moreover, there was a significant (P < .01) difference in the ATP content between the mild and severe
hypoxic groups (by Student's t test). However, the
extracellular glutamate concentration was markedly elevated during
exposure to hypoxia in the absence (46.03 ± 4.18 nmol/mg protein,
n = 6; P < .01 by Dunnett's test) or
presence of 3 mM glucose (9.20 ± 0.35 nmol/mg protein,
n = 6; P < .05 by Dunnett's test) as
compared with that in normoxic slices (0.32 ± 0.02 nmol/mg
protein, n = 6). In addition, a significant (P < .01) difference in the glutamate concentration
was observed between mild hypoxic and severe hypoxic slices (by
Student's t test).
|
Comparative Effects of NS-7 and
-CTX on Enhancement of
Extracellular Cyclic GMP Formation Induced by Various Concentrations of
KCl in Slices of Rat Cerebral Cortex.
As shown in Fig.
6, KCl (30-50 mM) produced a
concentration-dependent increase in the extracellular cyclic GMP
formation. NS-7 (10 µM) significantly reduced 50 mM KCl-induced
enhancement of the extracellular cyclic GMP formation without affecting
the response of 30 to 40 mM KCl (Fig. 6A). The values at 50 mM KCl were
670.1 ± 120.8% of basal values in the control group
(n = 6) and 329.0 ± 76.8% in the NS-7-treated
group (n = 6; P < .05 by Student's
t test), whereas those at 30 mM KCl were 145.0 ± 33.1% in the control group (n = 6) and 127.7 ± 31.8% in the NS-7-treated group (n = 6). In contrast,
-CTX (5 µM) almost completely blocked 30 mM KCl-evoked cyclic GMP
formation (Fig. 6B). The values at 30 mM KCl were 150.0 ± 15.9%
in the control group (n = 6) and 81.2 ± 15.3% in
the
-CTX-treated group (n = 6; P < .05 by Student's t test). However, it produced only a
slight and not significant inhibition of the response of 40 to 50 mM
KCl.
|
Comparative Effects of NS-7 and Nifedipine on KCl-Induced Elevation
of [Ca2+]i in Primary Neuronal Culture.
In this experiment,
[Ca2+]i was measured in
neurons on the fifth day of culture in which the
Ca2+ channels involved in the KCl-induced
increase in [Ca2+]i are
mostly L-type (Oka et al., 1999
). Therefore, the effect of NS-7
on [Ca2+]i was compared
with that of nifedipine. As shown in Fig.
7, 30 to 50 mM KCl increased
[Ca2+]i in a
concentration-dependent manner. NS-7 (30 µM) significantly reversed
the increase in [Ca2+]i
caused by 40 to 50 mM KCl without affecting the basal or KCl (30 mM)-evoked [Ca2+]i. The
inhibitory effect of NS-7 was more pronounced in the 50 mM KCl-evoked
response. Nifedipine (1 µM), however, produced almost complete
inhibition of the increase in
[Ca2+]i induced by 30 to
50 mM KCl.
|
| |
Discussion |
|---|
|
|
|---|
In our recent study in which hypoxic injury was determined by LDH
leakage in rat cerebrocortical slices after exposure to oxygen- and
glucose-deprived medium for 45 min, followed by reoxygenation for
6 h (Tatsumi et al., 1998b
), NS-7 (10-30 µM) significantly attenuated the tissue injury, whereas
-CTX, at a concentration (5 µM) that shows almost complete blockade of N-type
Ca2+ channel (Regan et al., 1991
), was effective
only when the peptide was treated in combination with a P/Q-type
Ca2+ channel blocker,
-Aga. Consistently, NS-7
markedly inhibited the tissue injury caused by the severe hypoxic
insult, and the significant effect was observed at 3 µM. However,
NS-7, even at 30 µM, had negligible action on the mild hypoxic
injury. In contrast, an
N-methyl-D-aspartate (NMDA) receptor
antagonist, MK-801, and an N-type Ca2+ channel
blocker,
-CTX, preferentially attenuated the mild hypoxic injury
with little, if any, protective effect on severe hypoxic damage.
It has been demonstrated that the release of an excitatory
neurotransmitter, glutamate, is elevated during cerebral ischemia. This
amino acid transmitter stimulates postsynaptic NMDA receptors and
-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate receptors, which allows Ca2+ to enter neurons
(Gleason and Spitzer, 1998
). The resultant elevation of
[Ca2+]i activates a
variety of Ca2+-dependent enzymes, including NOS,
and causes an irreversible neuronal damage (Orrenius et al., 1989
;
Choi, 1990
, 1992
; Kristián and Siesjö, 1998
).
In this study, the concentration of glutamate in the extracellular fluids was markedly elevated during 45 min of hypoxia and glucose deprivation, whereas in the presence of 3 mM glucose, the value was only one-fifth of that observed in the absence of glucose. Thus, it is likely that higher concentrations of glutamate receptor blockers, such as MK-801, are required to antagonize the actions of glutamate in the severe hypoxic model than are required to block the receptors in the mild hypoxic model.
In this study, L-NAME showed a cerebroprotective action,
although the NOS inhibitor was less effective in the severe injury model. Dawson et al. (1991)
have shown, in primary neuronal culture, that glutamate or NMDA stimulates NO formation, which is
determined by cyclic GMP accumulation, leading to neuronal death. It
also has been shown that the cerebral infarction caused by middle
cerebral artery occlusion is inhibited by a variety of NOS inhibitors
in mice (Nowicki et al., 1991
), rats (Ashwal et al., 1993
), and cats (Nishikawa et al., 1994
). Huang et al. (1994)
have demonstrated that
the size of cerebral infarction after middle cerebral artery occlusion
is smaller in mice genetically devoid of neuronal NOS. Moreover,
selective inhibitors of neuronal NOS, such as 7-nitroindazole and ARL
1744, have been demonstrated to decrease the infarct volume after
middle cerebral artery occlusion in rats (Dalkara et al., 1994
; Yoshida
et al., 1994
; Zhang et al., 1996
). Therefore, it is suggested that the
ischemic brain damage or hypoxic injury is mediated, at least in part,
by the enhancement of NO synthesis during ischemic or hypoxic
condition. In this study, the cyclic GMP formation in the extracellular
fluids was measured as an index of NO synthesis after addition of crude
extract of rat cerebellum (as the source of guanylate cyclase), GTP,
and IBMX to the incubation medium. We already have found that
hypoxia/glucose deprivation caused an enhancement of the extracellular
cyclic GMP formation, which was reduced by an NOS inhibitor, such as
L-NAME, and an intracellular Ca2+
chelator, BAPTA/AM, thereby suggesting that the extracellular cyclic
GMP formation results from the activation of
Ca2+-dependent (type I or type II) NOS (Oka et
al., 2000
), although the origin of the NOS (neuron or glial) is yet
unknown. In this study, the exposure to hypoxia/glucose deprivation
elicited a more pronounced increase in the extracellular cyclic GMP
formation than that measured in the presence of 3 mM glucose.
Therefore, it seems likely that the concentration of the NOS inhibitor
that is needed to block the NO synthesis and consequently inhibit
tissue injury is lower in the mild hypoxic injury model than in the
severe model.
Recently, we have found in primary neuronal culture that NS-7 (1-30
µM) inhibits the KCl-evoked NOS activity mediated through L-type and
P/Q-type Ca2+ channels in which the blockade is
almost complete at 30 µM. Moreover, the compound also suppresses the
NOS activation induced by high concentrations of Bay K 8644 (1-10
µM), a Ca2+ channel agonist; however, it has
little, if any, effect on the spontaneous activity or the responses of
low concentrations (0.01-0.1 µM) of Bay K 8644 (Oka et al., 1999
).
Moreover, NS-7, unlike other Na+ and
Ca2+ channel blockers, reduces the KCl (80 mM)-evoked dopamine release from rat striatum, measured by an
intracerebral microdialysis, without changing the spontaneous or evoked
release induced by 25 to 50 mM KCl (Itoh et al., 1998
). Also, in this
study, NS-7 inhibited the KCl-induced increase in
[Ca2+]i in primary
neuronal culture in a manner dependent on the extent of KCl
depolarization. Taken together, it is suggested that the blockade of
Ca2+ channel by NS-7 is dependent on the channel
activity in which the compound blocks preferentially the activated
Ca2+ channel.
During cerebral ischemia, depletion of ATP causes the dysfunction of
Na+/K+-ATPase and leads to
the elevation of intracellular Na+ concentration,
which in turn depolarizes neuronal membranes and subsequent activation
of voltage-gated Na+ and
Ca2+ channels. Thus, the depolarization of
neuronal membranes may be more marked when the hypoxic insults
are severe. The extent of ATP depletion is one of the determinants of
the severity of ischemic insults. In this study, tissue ATP content in
slices exposed to severe hypoxic condition (hypoxia/glucose
deprivation) was reduced to 5.4% of that in normoxic slices, whereas
the value was 14.1% in slices exposed to mild hypoxic condition
(hypoxia/3 mM glucose). Therefore, it is probable that NS-7 blocks more
effectively the highly activated Ca2+ channel
during severe ischemic condition with little, if any, blocking action
on the channel under nonischemic or mild ischemic condition.
Interestingly, the extent of cyclic GMP formation during exposure to
mild and severe hypoxic insult was similar to that induced by 30 to 40 mM KCl and 50 mM KCl, respectively. This may indicate that higher
numbers of Ca2+ channels are activated
during severe hypoxic insult. Under such a severe hypoxic condition,
most of the Ca2+ channels may be in the activated
and/or inactivated state. Several L-type Ca2+
channel blockers, such as verapamil and amlodipine, have been demonstrated to show higher affinity for the activated or inactivated state of Ca2+ channels and produce
voltage-dependent and use-dependent block of multiple high-voltage
activated Ca2+ channels, including L-type,
N-type, and P/Q-type Ca2+ channels (Cai et al.,
1997
; Furukawa et al., 1997
). It also has been demonstrated that the
sites of action of these Ca2+ channel blockers
for producing the state-dependent block are located within the sixth
transmembrane segment (S6) in domain IV of the
Ca2+ channel moiety (Hering et al., 1996
). Taken
together, the site of Ca2+ channel blockade by
NS-7 may be near the binding sites of these Ca2+
channel blockers.
In conclusion, both severe and mild hypoxic injury were induced in rat
cerebrocortical slices by an exposure to hypoxia for 45 min in the
absence and presence of 3 mM glucose, respectively, followed by
reoxygenation for 5 h. The extracellular cyclic GMP formation, a
marker of NO synthesis, was enhanced by the hypoxic insult, although
the enhancement was more marked in the absence of glucose than in the
presence of 3 mM glucose. NS-7, unlike MK-801,
-CTX, and
L-NAME, preferentially suppressed the tissue injury as well
as the enhancement of the cyclic GMP formation caused by severe hypoxic
insult. In slices exposed to 30 to 50 mM KCl for 45 min, a
concentration-dependent increase in the extracellular cyclic GMP
formation was observed. NS-7 blocked the enhancement of the cyclic GMP
formation induced by 50 mM KCl but not by 30 to 40 mM KCl. In primary
neuronal culture, NS-7 reversed KCl-induced elevation of
[Ca2+]i in which the
inhibition was marked when the KCl concentration was increased. These
findings indicate that the cerebroprotective action of a novel
Na+/Ca2+ channel blocker,
NS-7, is largely dependent on the severity of the hypoxic insult in
which the effect was more pronounced in severe injury. The highly
voltage-dependent blockade of Ca2+ channels may
participate in such a preferential action of NS-7.
| |
Footnotes |
|---|
Accepted for publication January 20, 2000.
Received for publication October 12, 1999.
Send reprint requests to: Michiko Oka, Research Laboratories, Nippon Shinyaku Co., Ltd., Nishiohji Hachijo Minami-ku, Kyoto 601, Japan. E-mail: m.oka{at}po.nippon-shinyaku.co.jp
| |
Abbreviations |
|---|
NOS, nitric-oxide synthase;
LDH, lactate
dehydrogenase;
[Ca2+]i, intracellular free
Ca2+ concentration;
KRB, Krebs-Ringer- bicarbonate
solution;
NO, nitric oxide;
NS-7, 4-(4-fluorophenyl)-2-methyl-6-(5-piperidinopentyloxy) pyrimidine
hydrochloride;
-CTX,
-conotoxin GVIA;
-Aga,
-agatoxin IVA;
L-NAME, NG-nitro-L-arginine methylester;
DMEM, Dulbecco's modified Eagle's minimum essential medium;
BAPTA/AM, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic
acid/acetoxymethyl ester;
IBMX, 3-isobutyl-1-methylxanthine;
NMDA, N-methyl-D-aspartate.
| |
References |
|---|
|
|
|---|
-agatoxin IVA protects against brain injury after focal ischemia in rats.
Brain Res
776:
140-145[Medline].
-adrenergic receptor-mediated cyclic AMP generating system in primary cultured neurons.
Int J Dev Neurosci
9:
347-356[Medline].
-conotoxin.
Neuron
6:
269-280[Medline].This article has been cited by other articles:
![]() |
E. Shi, T. Kazui, X. Jiang, N. Washiyama, K. Suzuki, K. Yamashita, and H. Terada NS-7, a novel Na+/Ca2+ channel blocker, prevents neurologic injury after spinal cord ischemia in rabbits J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 364 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Aoki, M. Tamura, Y. Itoh, T. Seto, K. Nonaka, H. Mukai, and Y. Ukai Effective Plasma Concentration of a Novel Na+/Ca2+ Channel Blocker NS-7 for Its Cerebroprotective Actions in Rats with a Transient Middle Cerebral Artery Occlusion J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 306 - 311. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||